Login / Signup

Disabilities Reporting in Cardiac Clinical Trials: How Are We Doing?

Roy H LanEli N RiceJulio C NunesRushil ShahJoseph-Kevin IgweKira ClarkVyjeyanthi S PeriyakoilJonathan H ChenBryant Y LinChristopher AwadMuhammed Yassin IdrisErin Rose CruzEldrin F LewisCati Brown JohnsonPaul J Wang
Published in: Journal of the American Heart Association (2023)
Keyphrases
  • clinical trial
  • left ventricular
  • adverse drug
  • phase ii
  • open label
  • randomized controlled trial
  • emergency department
  • double blind